<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Macrovascular disease is a major complication of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Epidemiological data suggest that the risk of macrovascular complications may predate the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0002155'>Hypertriglyceridemia</z:hpo>, low levels of <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi>, and an atherogenic profile characterize the <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>/<z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> that is also prevalent among nondiabetic members of familial type 2 diabetic kindreds </plain></SENT>
<SENT sid="3" pm="."><plain>To identify the genes for <z:chebi fb="23" ids="18059">lipid</z:chebi>-related traits, we first performed a 10-cM genome scan using 440 markers in 379 members of 19 multiplex families ascertained for two diabetic siblings (screening study) </plain></SENT>
<SENT sid="4" pm="."><plain>We then extended findings for three regions with initial logarithm of odds (LOD) scores &gt;1.5 to an additional 23 families, for a total of 576 genotyped individuals (extended study) </plain></SENT>
<SENT sid="5" pm="."><plain>We found heritabilities for <z:hpo ids='HP_0000001'>all</z:hpo> <z:chebi fb="23" ids="18059">lipid</z:chebi> measures in the range of 0.31 to 0.52, similar to those reported by others in unselected families </plain></SENT>
<SENT sid="6" pm="."><plain>However, we found the strongest evidence for linkage of <z:chebi fb="0" ids="17855">triglyceride</z:chebi> levels to chromosome 19q13.2, very close to the ApoC2/ApoE/ApoC1/ApoC4 gene cluster (LOD 2.56) in the screening study; the LOD increased to 3.16 in the extended study </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="17855">Triglyceride</z:chebi>-to-<z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> ratios showed slightly lower LOD scores (2.73, extended family) in this same location </plain></SENT>
<SENT sid="8" pm="."><plain>Other regions with LOD scores &gt;2.0 included <z:chebi fb="17" ids="39025">HDL</z:chebi> linkage to chromosome 1q21-q23, where susceptibility loci for both familial type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and familial <z:hpo ids='HP_0008356'>combined hyperlipidemia</z:hpo> have been mapped, and to chromosome 2q in the region of the NIDDM1 locus </plain></SENT>
<SENT sid="9" pm="."><plain>Neither region showed stronger evidence for linkage in the extended studies, however </plain></SENT>
<SENT sid="10" pm="."><plain>Our results suggest that genes in or near the ApoE/ApoC2/ApoC1/ApoC4 cluster on 19q13.2 may contribute to the commonly observed <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo> and low <z:chebi fb="17" ids="39025">HDL</z:chebi> seen in diabetic family members and their offspring, and thus may be a candidate locus for the <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> syndrome </plain></SENT>
</text></document>